PCN6 Impact of 5-HT3 Receptor Antagonist Selection Within Triple Antiemetic Regimens on the Risk of Uncontrolled Chemotherapy-Induced Nausea in Patients with Cancer Treated with Highly Emetogenic Chemotherapy
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1107
https://www.valueinhealthjournal.com/article/S1098-3015(11)02669-6/fulltext
Title :
PCN6 Impact of 5-HT3 Receptor Antagonist Selection Within Triple Antiemetic Regimens on the Risk of Uncontrolled Chemotherapy-Induced Nausea in Patients with Cancer Treated with Highly Emetogenic Chemotherapy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02669-6&doi=10.1016/j.jval.2011.08.1107
First page :
A434
Section Title :
Cancer
Open access? :
No
Section Order :
1066